Evidence map›Paper›PMID 42593544›Full record

ArticleMikrochimica acta2026

Programmable two-dimensional CoOOH nanosheets with a hybridization chain reaction amplification system for label-free fluorescent detection of miRNA-205 in colorectal cancer.

Wenpei Dong, Xingda Huang, Feng Zhang, Tongshan Zuo, Xinyi Xia, Ping Yu, Dongchao Yang, Zhicheng Song, Xia Cheng, Jing Zhang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenpei Dong *Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Xingda Huang *Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Feng Zhang *Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Tongshan ZuoHangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Xinyi XiaDepartment of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ping YuDepartment of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dongchao YangDepartment of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Zhicheng SongDepartment of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Xia ChengDepartment of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Chengxia199405@163.com.ORCID https://orcid.org/0000-0001-5421-4715
Jing ZhangDepartment of Periodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, China. zjcrystal1118@163.com.
Jianjun YangDepartment of General Surgery, Huadong Hospital, Fudan University, Shanghai, China. ayang1230@126.com.
Yan GuDepartment of General Surgery, Huadong Hospital, Fudan University, Shanghai, China. yangu@fudan.edu.cn.

Funding

Elite Innovation and Research Projects of Ruijin Hospital JYCY-2025-002Elite Innovation and Research Projects of Ruijin Hospital JYCY-2025-015Huadong Hospital Basic Research Promotion Program JCTS2025001National Natural Science Foundation of China 62305207National Natural Science Foundation of China 82204349National Natural Science Foundation of China 82570602National Youth Medical Innovation Research Project P250320108852National Youth Medical Innovation Research Project P250530109214Shanghai Youth Pharmaceutical Talent Capacity Enhancement Program SPAQNRC2025A15
6 · The paper itself

Abstract

MicroRNA-205 (miRNA-205) has been identified as a promising biomarker, yet its clinical application is hindered by the lack of detection strategies that combine simplicity, ultrahigh sensitivity, and high specificity. To address these obstacles, we introduced an innovative biosensor integrating hybridization chain reaction (HCR) with two-dimensional CoOOH nanosheets for precisely detecting the colorectal cancer biomarker miRNA-205 (HCR-CoOOH system). This system took advantage of the preferential binding of CoOOH nanosheets for single-stranded DNA over double-stranded DNA, along with HCR for signal amplification. Without the target miRNA-205, hairpin probes H1 and H2 were adsorbed onto CoOOH nanosheets, resulting in effective FRET-based quenching of the intercalated SYBR Green I fluorescence. In contrast, introduction of the target triggered the HCR cascade, producing numerous long double-stranded DNA polymers. Low affinity between these duplexes and the nanosheets allowed substantial fluorescence recovery under isothermal conditions. A strong linear relationship was observed between fluorescence recovery and miRNA-205 concentration over 0.1-500 nM, with a detection limit of 0.062 nM. Furthermore, the system demonstrated excellent specificity and robust performance in serum samples. Notably, this work circumvented the issues of tedious handling and strong background interference by enabling a swift switch from the "signal-off" to the "signal-on" detection mode, while also simplifying the workflow and reducing non-specific signals. Furthermore, the use of SYBR Green I eliminated the need for covalent fluorophore labeling, markedly reducing assay cost. This versatile strategy provides a valuable new tool for colorectal cancer research and clinical diagnostics.

Indexed as

Colorectal NeoplasmsMicroRNAsNanostructuresBenzothiazolesBiosensing TechniquesCobaltDiaminesFluorescence Resonance Energy TransferFluorescent Chemosensor CompoundsFluorescent DyesHumansLimit of DetectionNucleic Acid Amplification TechniquesNucleic Acid HybridizationOxidesQuinolinesBenzothiazolesCobaltDiaminesFluorescent Chemosensor CompoundsFluorescent DyesMicroRNAsMIR205, humanOxidesQuinolinesSYBR Green IColorectal cancerHybridization chain reactionMicroRNA determinationSignal amplificationTwo-dimensional nanosheets

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.